Liaw YF - Search Results

1

Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.

Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw YF, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C. Wei L, et al. Among authors: liaw yf. J Viral Hepat. 2019 Sep;26(9):1040-1049. doi: 10.1111/jvh.13107. Epub 2019 Jul 23. J Viral Hepat. 2019. PMID: 30972912 Free article. Clinical Trial.

2

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. Yu MW, et al. Among authors: liaw yf. J Natl Cancer Inst. 2005 Feb 16;97(4):265-72. doi: 10.1093/jnci/dji043. J Natl Cancer Inst. 2005. PMID: 15713961

3

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.

Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, Gane E, Kao JH, Omata M; Asian-Pacific consensus update working party on chronic hepatitis B. Liaw YF, et al. Liver Int. 2005 Jun;25(3):472-89. doi: 10.1111/j.1478-3231.2005.01134.x. Liver Int. 2005. PMID: 15910483 Review.

4

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.

Lin SM, Yu ML, Lee CM, Chien RN, Sheen IS, Chu CM, Liaw YF. Lin SM, et al. Among authors: liaw yf. J Hepatol. 2007 Jan;46(1):45-52. doi: 10.1016/j.jhep.2006.08.021. Epub 2006 Oct 20. J Hepatol. 2007. PMID: 17107734

5

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.

Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC, Cooksley G, Luo KX, Paik SW, Liaw YF, Button P, Popescu M. Fried MW, et al. Among authors: liaw yf. Hepatology. 2008 Feb;47(2):428-34. doi: 10.1002/hep.22065. Hepatology. 2008. PMID: 18220290

6

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han SH, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, Chen Y, Brown NA, Albanis E, Galil K, Naoumov NV; GLOBE Study Group. Liaw YF, et al. Gastroenterology. 2009 Feb;136(2):486-95. doi: 10.1053/j.gastro.2008.10.026. Epub 2008 Nov 1. Gastroenterology. 2009. PMID: 19027013 Clinical Trial.

7

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.

Liaw YF. Liaw YF. Liver Int. 2009 Jan;29 Suppl 1:100-7. doi: 10.1111/j.1478-3231.2008.01941.x. Liver Int. 2009. PMID: 19207972 Review.

8

Hepatitis B virus infection.

Liaw YF, Chu CM. Liaw YF, et al. Lancet. 2009 Feb 14;373(9663):582-92. doi: 10.1016/S0140-6736(09)60207-5. Lancet. 2009. PMID: 19217993

9

On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future.

Liaw YF. Liaw YF. Antivir Ther. 2009;14(1):13-22. Antivir Ther. 2009. PMID: 19320233 Review.

10

Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.

Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Tai DI, et al. Among authors: liaw yf. Hepatology. 2009 Jun;49(6):1859-67. doi: 10.1002/hep.22878. Hepatology. 2009. PMID: 19378345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

554 results

Search Page